INTER-ARRAY combines bioanalytics with state-of-the-art microtechnologies, especially in the field of high precision microdispensing. INTER-ARRAY is partner of companies and institutions in the fields of medicine and medical technology, diagnostics, environmental analysis and pharmaceutical development. INTER-ARRAY is part of fzmb GmbH, Research Center for Medical Technology and Biotechnology (Germany), which has extensive experience in immunochemistry, biomedicine and bioanalytics. INTER-ARRAY supports its partners in all microarray development stages, from feasibility study, optimization, verification and validation to pilot production. INTER-ARRAY offers solutions for multiparameter assay development and validation for any application in human and veterinary diagnostics and life sciences. INTER-ARRAY is a full service provider in the life science sector with its protein and antibody, molecular, microbiology, bioconjugation and surface technology labs. INTER-ARRAY Genotyping Kits allow DNA-based detection of antibiotic resistance genes, virulence genes and pathogenicity markers of different multi-resistant pathogens by simple and quick assignment of unknown isolates to known strains within hours. Founded in 1994 by biotechnologists, engineers and physicians, the ISO-certified company today develops and manufactures innovative, high-quality diagnostic products for laboratory and point-of-care applications.
Bad Langensalza, Germany
Founded in 1994
11-50 Employees
Working industry
Biotechnology
Type of company
Educational institution, Service provider, Manufacturer
Ownership structure
Nonprofit
Locations
1 Headquarter
Specialised areas
ultra-low volume dispensing, microarray, bioanalytics, antibiotic resistance, S.aureus genotyping, contract manufacturing, high precision dispensing, multiplex assays, assay development, biosensors
An estimation about the ESG values based on digital data and signals. Important: The ESG scores are only based on information about the country, not the actual company itself
Country:
Germany
Overall risk estimation:
Very low
The ESG Data of countries are based on public sources
Environment
A
Grade (A-E)
View details
Social
A
Grade (A-E)
View details
Governance
A
Grade (A-E)
View details
INTER-ARRAY by fzmb GmbH operates in 1 country around the world
Get an overview of the locations of INTER-ARRAY by fzmb GmbH
Location
Country
State
City
Headquarter
Germany
Thuringia
Bad Langensalza
Some frequent questions that have been asked about INTER-ARRAY by fzmb GmbH
Where is INTER-ARRAY by fzmb GmbH located?
The company headquarter of INTER-ARRAY by fzmb GmbH is located in Bad Langensalza, Thuringia, Germany. It's worth noting, that the company may have more locations
How many employees does INTER-ARRAY by fzmb GmbH approximately have?
As of the latest available information INTER-ARRAY by fzmb GmbH has around 11-50 employees worldwide.
When was INTER-ARRAY by fzmb GmbH founded?
INTER-ARRAY by fzmb GmbH was founded in 1994
In which industries does INTER-ARRAY by fzmb GmbH mainly work?
The company INTER-ARRAY by fzmb GmbH has it's main focus in the industries of Biotechnology
Check out some interesting alternative companies to INTER-ARRAY by fzmb GmbH
Arrayit
Sunnyvale, United States
1-10 Employees
1993
Arrayit customers include the brightest minds in university laboratories, government laboratories, biotechnology companies, life sciences companies, clinical laboratories, pharmaceutical companies and hospitals worldwide. Arrayit microarray technology empowers scientists with the tools required to make important discoveries and change the world. Arrayit microarray technology products and services are featured in more than 6,000 peer-reviewed scientific publications, for the ultimate in scientific credibility. Arrayit microarray technology miniaturizes traditional tests by 100-fold or more, which reduces manufacturing and personnel costs, increases testing throughput and packs tremendous scientific content into each research test. Arrayit microarray technology affords life sciences researchers with the tools required to identify these markers, leading potentially to transformative healthcare advances. Arrayit offers a full suite of microarray-based products and services to empower researchers with the tools required to make next generation discoveries for human kind. Arrayit sets the standard in the microarray industry with ArrayIt® Brand DNA Microarrays. Arrayit sets the standard for the microarray industry with ArrayIt® brand Purification Products.
Aquarray
Eggenstein-Leopoldshafen, Germany
1-10 Employees
2018
Aquarray is a privately held German biotech company developing a proprietary technology platform, the Droplet Microarray (DMA), which enables highly miniaturized assays, screenings and analyzes. Aquarray is a spin-off from the Karlsruhe Institute of Technology (KIT), Germany, founded in early 2018 by Konstantin Demir, Gunter Festel, Michael Grunze, Pavel Levkin, Anna Popova, Jörg Vienken and Simon Widmaier. We at Aquarray aim to pave the way by taking miniaturization to a new level with our groundbreaking technology – the Droplet Microarray! With the DMA, Aquarray provides a decisive technology to realize this intent – specifically one that is designed to work with standard laboratory equipment! Founded as a spin-off from the Karlsruhe Institute of Technology, Aquarray's technology is based on a unique surface structure that enables a dense grid of nano-volume reaction vessels. Together, we aim to take miniaturization to a new level and provide a solution that enables the development of novel, more effective workflows and screenings in areas where the availability of reagents, materials or cells is limited, paving the way for new applications. Tim Friedrichson has more than 20 years of experience in and with biotech startups. Harry's focus and passion is the commercial implementation of disruptive technologies.
engine the biomarker company
Hennigsdorf, Germany
1-10 Employees
-
We are your engine for your biomarker discovery! We are the legal successor of RZPD, imaGenes, Source Biosciences. Our products and services are made by scientists for scientists. This work has built the basis for the engine protein arrays. Therefore we work intensively with our partners to offer our customers solutions in all areas. One focus of the Unit Molecular Diagnostics is provide services with its innovative high throughput technologies, using protein and peptide microarrays, bead arrays, multiplex protein like pre-defined and customized analysis and assay development.
Applied Microarrays
Tempe, United States
101-250 Employees
2007
Applied Microarrays (“AMI”) was founded in 2006 by CEO Alastair Malcolm, with the business model of manufacturing Point-of-Care and High Throughput DNA and protein arrays whose custom bio-content is developed by AMI’s customers. The array manufacturing equipment from GE has unique features enabling quality, accuracy and repeatability not available in tools sold on the general market. In October 2021 AMI was acquired by SCHOTT MINIFAB, a world leading microfluidic diagnostics and lifescience company. Combined, AMI and SCHOTT MINIFAB have a team of over 300 specialists with manufacturing sites in Europe, Australia and USA. Accordingly we treat our customer engagements with quality systems that will enable their products to be accepted successfully in regulated markets.
ArrayXpress
Raleigh, United States
11-50 Employees
2002
ArrayXpress is a genomics services company founded with the vision of providing a complete solution for anyone needing to implement genomic technologies in their research agenda. ArrayXpress was founded in January 2003 as a Delaware “C” corporation and maintains its principal place of business in Raleigh, North Carolina. ArrayXpress specializes in three main markets; Toxic Tort, Bioprocess Optimization, and Agriculture. ArrayXpress combines cutting edge next generation genomics technologies and innovative statistical and bioinformatics analytical approaches to develop and conduct investigational studies for pharmaceutical, medical, academic and agricultural clients. We provide the tools and workflows that will insure client success and maximize the impact of their scientific studies. At ArrayXpress, our strongest value for clients comes from the knowledge, skills and experience of our team. Using primarily Next Generation Sequencing (NGS) technology, we specialize in designing and executing tailored, customized scientific projects to answer our clients’ biological/scientific questions. By partnering with us, our clients can focus on their scientific hypothesis and experimentation, completely eliminating the need to invest significant resources to bring internally such rapidly evolving technology and high cost instrumentation.
ArrayGen Technologies Private Limited
Pune, India
1-10 Employees
2014
ArrayGen Technologies Pvt Ltd is:Genomics service provider both National and International Next Generation Sequencing(NGS) Data Analysis Microarray Data analysis Computer Aided Drug Designing Custom Bioinformatics Services Provider Research and Development Cancer Genomics Training Provider in Bioinformatics (Genomics) Providing World Class Industrial Training to Students/Researcher/Scientist Nurturing and learning the technology to get Placement Supports for training in both Offline/Online Certificate will be issued on successfull completion of course Developing Bioinformatics Algorithm Separate Division to Develop tools for NGS data and software development Developing Novel algorithm to help their publication. ArrayGen has a great expertise in Genomics and we constantly endeavour to surpass the expectations of our customers. ArrayGen Technologies Pvt Ltd promises quality assurance, customer focused, reliability and trust from all its Genomics Services. We focus on innovation in style of Genomics and bringing novelty. Gene Expression Arrays is a microarray design catalog created by ArrayGen. The ANG Genome Browser is a visualization tool, developed by ArrayGen Technologies Pvt. This is a fast and an efficient genome browser, built with Javafx and Java swing. ANG Genome Browser was built for latest next generation sequencing data analysis.